This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jcr Pharmaceuticals Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Mitsugu Fujita: Innovator in Hypercoagulation Research
Introduction
Mitsugu Fujita is a notable inventor based in Inami-cho, Japan. He has made significant contributions to the field of medical research, particularly in the area of blood coagulation. His innovative work has led to the development of a unique suppressory agent against hypercoagulation.
Latest Patents
Fujita holds a patent for suppressory agents against hypercoagulation. This invention comprises an effective ingredient, a protein C inhibitor with a molecular weight of 54 to 57 kDa (DS-PAGE), which is capable of suppressing the function of the blood coagulation system. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Mitsugu Fujita is associated with JCR Pharmaceuticals Co., Ltd., where he continues to engage in groundbreaking research. His work at this company has positioned him as a key figure in the development of innovative medical solutions.
Collaborations
Fujita has collaborated with esteemed colleagues, including Yoshikazu Komurasaki and Keihide Koh. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Mitsugu Fujita's contributions to the field of hypercoagulation research exemplify his dedication to innovation and medical advancement. His patent and collaborations reflect his significant impact on the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile